Leading Independent Investment Research, Morningstar, Inc.

Morningstar

Leading Independent Investment Research

Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. We offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. 

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 16 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries, with more than $180 billion in assets under advisement or management as of June 30, 2015. We have operations in 27 countries.

Download the Morningstar Fact Sheet : http://corporate.morningstar.com/US/documents/MarketingFactSheets/AboutMorningstarFactsheet.pdf

Equity Bottom-Up

Our AUD 6.00 fair value estimate is unchanged. Nufarm shares have largely held on to the strong 40% price gains from AUD 6.30 February 2016 lows, and at AUD 8.80 we think remain materially overvalued.We think the market is pricing in potential for a takeover bid while our fair value is necessarily on a stand-alone basis. Nufarm's potential longer-term worth to a corporate/sovereign buyer wanting a safe beachhead in close proximity to end markets, could see its shares continue to trade higher than our fair value for an extended period. Even if Nufarm itself doesn’t become prey, required third-party divestments as deals progress could present opportunities.Analyst: Mark Taylor

Our AUD 6.00 fair value estimate is unchanged. Nufarm shares have largely held on to the strong 40% price gains from AUD 6.30 February 2016 lows, and at AUD 8.80 we think remain materially overvalued.We think the market is pricing in potential for a takeover bid while our fair value is necessarily on a stand-alone basis. Nufarm's potential longer-term worth to a corporate/sovereign buyer wanting a safe beachhead in close proximity to end markets, could see its shares continue to trade higher than our fair value for an extended period. Even if Nufarm itself doesn’t become prey, required third-party divestments as deals progress could present opportunities.Analyst: Mark Taylor

Our AUD 6.00 Nufarm Fair Value Estimate Stands Despite Share Price Strength

M&A Reporting, CTFN

Jonathan Spitzer

M&A Reporting

CTFN

Bringing the marketplace leading coverage of mergers, events, and major corporate actions, CTFN has a team of seasoned reporters from Los Angeles to London, publishing news that advances stories that matter to event-driven investors and deal professionals.

Event-Driven

The African Centre for Biodiversity (ACB), a Johannesburg-based non-profit organization promoting food sovereignty and campaigning against corporate control of Africa’s food resources, is going to file comments against the ongoing agrochemical mergers with the Competition Commission of South Africa, and will ask the regulator to review the approval of the Syngenta/ChemChina deal, Mariam Mayet, the center’s founder and director, told CTFN.

The African Centre for Biodiversity (ACB), a Johannesburg-based non-profit organization promoting food sovereignty and campaigning against corporate control of Africa’s food resources, is going to file comments against the ongoing agrochemical mergers with the Competition Commission of South Africa, and will ask the regulator to review the approval of the Syngenta/ChemChina deal, Mariam Mayet, the center’s founder and director, told CTFN.

African Non-Profit to Fight Agrochem Mergers

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

It's the end of the year - time to reflect on the past year, spend time with friends &amp; family, think about changes to one's portfolio, and watch good movies!We are switching into XLB Materials ETF (XLB US) and take out <a href="https://www.smartkarma.com/entities/22660" target="_blank" data-smartkarma-citation="entities:22660:1">Samsung Kodex Securities Etf</a> (102970 KS) from our model portfolio. We believe that the XLB Materials ETF has a better risk-adjusted potential returns as compared to the <a href="https://www.smartkarma.com/entities/22660" target="_blank" data-smartkarma-citation="entities:22660:1">Samsung Kodex Securities Etf</a>. Three major reasons why we prefer XLB is due to 1) higher US infrastructure…

It's the end of the year - time to reflect on the past year, spend time with friends &amp; family, think about changes to one's portfolio, and watch good movies!We are switching into XLB Materials ETF (XLB US) and take out Samsung Kodex Securities Etf (102970 KS) from our model portfolio. We believe that the XLB Materials ETF has a better risk-adjusted potential returns as compared to the Samsung Kodex Securities Etf. Three major reasons why we prefer XLB is due to 1) higher US infrastructure…

Switch into XLB Materials ETF (What Did You Notice in the First Three Minutes of La La Land?)

Bayer’s $66 billion bid for genetically modified seed and herbicide producer Monsanto faces strong opposition from a range of stakeholders in South Africa and neighboring countries, sources told CTFN.

Bayer’s $66 billion bid for genetically modified seed and herbicide producer Monsanto faces strong opposition from a range of stakeholders in South Africa and neighboring countries, sources told CTFN.

Monsanto/Bayer Merger to Face Opposition in Africa

Monsanto is likely to profit from Brazil’s economic crisis, as the country − the world’s largest soybean exporter − strives to boost production and retain foreign investors amid an uncertain political and financial outlook.

Monsanto is likely to profit from Brazil’s economic crisis, as the country − the world’s largest soybean exporter − strives to boost production and retain foreign investors amid an uncertain political and financial outlook. 

Monsanto Progresses Soybean Business in Brazil

United States

Monsanto Company provides agricultural products for farmers. The Company's business segments are seeds and genomics. Monsanto produces a wide range of seeds and develops biotechnology traits that assist farmers in controlling insects and weeds as well as provides other seed companies with genetic material and biotechnology traits for their seed brands.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Monsanto Co (MON US)

Our AUD 6.00 Nufarm Fair Value Estimate Stands Despite Share Price Strength

Our AUD 6.00 fair value estimate is unchanged. Nufarm shares have largely held on to the strong 40% price gains from AUD 6.30 February 2016 lows,...

Morningstar, Inc.

African Non-Profit to Fight Agrochem Mergers

The African Centre for Biodiversity (ACB), a Johannesburg-based non-profit organization promoting food sovereignty and campaigning against...

CTFN

Switch into XLB Materials ETF (What Did You Notice in the First Three Minutes of La La Land?)

It's the end of the year - time to reflect on the past year, spend time with friends & family, think about changes to one's portfolio, and...

Douglas Kim

Monsanto/Bayer Merger to Face Opposition in Africa

Bayer’s $66 billion bid for genetically modified seed and herbicide producer Monsanto faces strong opposition from a range of stakeholders in South...

CTFN

Monsanto Progresses Soybean Business in Brazil

Monsanto is likely to profit from Brazil’s economic crisis, as the country − the world’s largest soybean exporter − strives to boost production and...

CTFN

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)